Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer
144 patients will be included; 72 per arm. * "Standard" Control arm: patient supported by the onco-respiratory service. * Intervention arm: patients benefit from early palliative care in addition to standard onco-pneumologic care. The main criterion of judgment is the TOI score measured at 12 weeks. FACTL questionnaires, HADS and PHQ-9 will be filled out before randomization , at 12 weeks and 21 weeks
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
71
multi disciplinary palliative care consultations with a doctor, a nurse, a psychologist and posibility of a physical therapist and a worship person.The primary consultation within 3 weeks inclusion and then every month at the same time that consultations onco-respiratory
CHRU, Hôpital Claude Huriez
Lille, France
quality of life
quality of life is measured at 12 weeks by the TOI score
Time frame: 12 weeks
SURVIVAL
Time frame: from baseline
EVENTS
presence of any of the following: chemotherapy, use of resuscitation or no treatment limiting decision 14 days before deaths
Time frame: 14 days before deaths
QUALITY OF LIFE
quality of life is measured by the score TOI at 12 weeks and by the Echelle SCNS - SF34 scale, FACTL, PHQ-9 and HADS questionnaires at 12 and 21 weeks
Time frame: 12 and 21 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.